Audience & Objectives
High Impact Hepatology: Updates from the Major Liver Meetings
November 4, 2017 at the Rizzo Conference Center, Chapel Hill, NC
Physicians, Fellows, Residents, Physician Assistants, Nurses/Nurse Practitioners, and Pharmacists.
At the conclusion of the knowledge-based activity, the learner should be able to:
- Discuss the impact of therapy on the natural history of chronic hepatitis C.
- Identify the success and limitations of new treatment modalities for chronic hepatitis B and hepatitis C.
- Integrate the latest clinical trials data into the management of individual patients in order to maximize treatment outcomes for chronic liver disease, such as NASH, primary biliary cholangitis and other liver diseases.
- Review new concepts in the management of complications of end-stage liver disease, including the management of portal hypertension, hepatic encephalopathy, and hepatocellular carcinoma.